Pfizer\u304cInflammation & Immunology\u306b\u95a2\u3059\u308b\u6280\u8853\u3092\u52df\u96c6\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n
The Inflammation & Immunology Research Unit, led by Michael Vincent, Chief Scientific Officer, is focused on discovering, evolving and developing the next generation of therapies for immune-mediated diseases. Pfizer is interested in entering into strategic relationships with innovative collaborators to develop increasingly novel and differentiated therapies in Rheumatology, Gastroenterology and Medical Dermatology.<\/p>\n
We are interested in establishing alliances to develop and access:<\/p>\n
-Rheumatoid Arthritis -Systemic Lupus Erythematosus -Inflammatory Bowel Disease<\/p>\n
-Nonalcoholic steatohepatitis (NASH)<\/p>\n
-Atopic Dermatitis<\/p>\n
-Other indications with high unmet need that are mechanistically related to those above Specific areas of interest include:<\/p>\n
-Cytokines and their signaling pathways<\/p>\n
-Adaptive Immunity, Lymphocyte biology including Th17 lymphocytes<\/p>\n
-Regulatory cells and Tolerance induction<\/p>\n
-Host-microbial interactions and microbiome with an interest in epithelial barrier -Innate Immunity and Innate Lymphoid Cell biology<\/p>\n
-Oxidative stress modulators<\/p>\n
-Anti-fibrotics<\/p>\n
-Technology platforms and products to help understand patient segmentation in the disease areas of interest and develop precision medicine strategies for innovative portfolio products<\/p>\n
-Technology platforms and products that allow for greater tissue and cell specific delivery<\/p>\n
\u4ee5\u4e0a\u306e\u6280\u8853\u30cb\u30fc\u30ba\u306f\u3001Pfizer\u304c\u516c\u5f0f\u30a6\u30a7\u30d6\u30b5\u30a4\u30c8\u306b\u3066\u958b\u793a\u3057\u305f\u3082\u306e\u3092\u53d6\u5f97\u3057\u305f\u3082\u306e\u3067\u3042\u308a\u3001\u5f0a\u793e\u306f\u5f53\u8a72\u30cb\u30fc\u30ba\u63d0\u4f9b\u8005\u306e\u4ee3\u7406\u4eba\u3067\u306f\u3042\u308a\u307e\u305b\u3093\u3002<\/p>\n","protected":false},"author":18,"featured_media":1333,"template":"","meta":{"_company_name":"Pfizer","_job_location":"","_application":"skimura@keisenassociates.com","_company_tagline":"Pfizer\u304cInflammation & Immunology\u306b\u95a2\u3059\u308b\u6280\u8853\u3092\u52df\u96c6\u3057\u3066\u3044\u307e\u3059\u3002","_company_video":"","_company_website":"https:\/\/www.pfizer.com\/partners\/highlights","_company_twitter":"","_filled":0,"_featured":0,"_remote_position":0,"_job_salary":"","_job_salary_currency":"","_job_salary_unit":""},"job_listing_region":[],"job-categories":[65,68,70],"job-types":[52,53],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-listings\/1477"}],"collection":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-listings"}],"about":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/types\/job_listing"}],"author":[{"embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/users\/18"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/media\/1333"}],"wp:attachment":[{"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/media?parent=1477"}],"wp:term":[{"taxonomy":"job_listing_region","embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job_listing_region?post=1477"},{"taxonomy":"job_listing_category","embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-categories?post=1477"},{"taxonomy":"job_listing_type","embeddable":true,"href":"https:\/\/www.nikola.jp\/needs\/wp-json\/wp\/v2\/job-types?post=1477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}